AI entity
AI Medical Scribes is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Across a 25-day span, the pace is roughly 0.6 stories per week. The 7 average consequence score is above the beat benchmark of 6.7 in the same window.
Last mentioned: Feb 27, 2026
Entity pulse
Coverage balance Balanced directional read. Positive and negative coverage are within 0 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
AI Medical Scribes is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. Across a 25-day span, the pace is roughly 0.6 stories per week. The 7 average consequence score is above the beat benchmark of 6.7 in the same window. product-launch accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Source depth averages 2.5 original sources per story, versus 2.7 across the same-window beat baseline. This profile follows 2 AI stories mentioning TGA across the period from February 27, 2026 to March 23, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 808 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering TGA. Shared-story counts are live from our verified record — not editorial picks.
TGA Approval
Australian regulatory body approves the platform for clinical use in Australia.
CE Mark
Virtual Nodule Clinic receives CE marking for expansion into European markets.
Series A Funding
Company raises $14M to scale its AI platform globally.
FDA Clearance
Optellum receives first-of-its-kind FDA clearance for AI lung cancer decision support.
Australia's Therapeutic Goods Administration (TGA) has initiated a formal review of AI-powered clinical documentation tools following concerns over their susceptibility to manipulation. The investigation marks a significant regulatory shift as authorities move to ensure the integrity of AI-generated medical records.
Optellum has received regulatory clearance from Australia’s Therapeutic Goods Administration (TGA) for its AI-powered Virtual Nodule Clinic. This milestone allows the company to deploy its lung cancer early-detection technology across the Australian healthcare system, marking a major expansion into the Asia-Pacific market.
TGA is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
